Tuesday 30th July 2024 |
Text too small? |
AUCKLAND, 30 July 2024: Fleet management and transport technology software company EROAD Limited (NZX: ERD , ASX: ERD) has today published its Group Climate Statement for the reporting period ended 31 March 2024.
This report reflects the first disclosures prepared in accordance with the Aotearoa New Zealand Climate Standards. The report seeks to provide stakeholders with an understanding of the actions that EROAD is taking to identify and manage climate-related risks and opportunities, and the potential implications of climate change on its business.
EROAD's FY24 Group Climate Statement is available in the Investors section of EROAD's website at: https://eroadglobal.com/investors/ . For further information please contact: Ksenija Chobanovich, General Counsel & Company Secretary, EROAD Limited.
ENDS
Authorised for release to the NZX and ASX by EROAD’s General Counsel & Company Secretary, Ksenija Chobanovich.
For Investor enquiries please contact:
Jason Kepecs
Jason.kepecs@eroad.com
NZ contact: +64 21 990 474
AU contact: +61 47 7711 136
For Media enquiries please contact:
Richard Llewellyn
richard@shanahan.nz
+64 27 523 2362
About EROAD
EROAD is a fully integrated technology, tolling and services provider, based in Auckland, New Zealand. They were the first company in the world to implement a GNSS/cellular-based road charging solution across an entire country. They design and manufacture in-vehicle hardware, operate secure payment and merchant gateways and offer web-based value-added services. EROAD modernises road charging and compliance for road transport by replacing paper-based systems with easy-to-use electronic systems. They are the largest provider of road user charges (RUC) compliance in New Zealand, and a leading provider of health and safety compliance and fleet management solutions. EROAD is listed on the New Zealand Stock Exchange (NZX) and Australian Stock Exchange (ASX) under the stock symbol of ERD.
No comments yet
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report